American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$233M |
| 2 |
Workday
WDAY
|
+$177M |
| 3 |
Eli Lilly
LLY
|
+$174M |
| 4 |
Apple
AAPL
|
+$171M |
| 5 |
Agree Realty
ADC
|
+$123M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$486M |
| 2 |
Colgate-Palmolive
CL
|
+$230M |
| 3 |
NXP Semiconductors
NXPI
|
+$192M |
| 4 |
Merck
MRK
|
+$172M |
| 5 |
Duke Energy
DUK
|
+$170M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.52% |
| 2 | Financials | 13.4% |
| 3 | Consumer Discretionary | 11.51% |
| 4 | Healthcare | 11.17% |
| 5 | Industrials | 10.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2751
PetMed Express
PETS
$43M
| $107K | ﹤0.01% |
29,203
+2,973
| +11% | +$10.5K |
|
2752
Zegna
ZGN
$3.76B
| $107K | ﹤0.01% |
10,840
| – | – |
|
2753
Sera Prognostics
SERA
$79.1M
| $104K | ﹤0.01% |
13,381
-12,301
| -48% | -$89.3K |
|
2754
Century Casinos
CNTY
$34.3M
| $103K | ﹤0.01% |
40,387
| – | – |
|
2755
Relmada Therapeutics
RLMD
$503M
| $102K | ﹤0.01% |
31,554
-64
| -0.2% | -$207 |
|
2756
Oportun Financial
OPRT
$346M
| $102K | ﹤0.01% |
36,181
-980
| -3% | -$2.85K |
|
|
PSTX
2757
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $100K | ﹤0.01% |
35,074
-55,413
| -61% | -$172K |
|
2758
inTEST
INTT
$179M
| $99.1K | ﹤0.01% |
13,581
-1,092
| -7% | -$9.06K |
|
2759
Corvus Pharmaceuticals
CRVS
$1.27B
| $96.1K | ﹤0.01% |
18,208
-40
| -0.2% | -$144 |
|
2760
VistaGen Therapeutics
VTGN
$11.6M
| $90.9K | ﹤0.01% |
30,197
-118
| -0.4% | -$403 |
|
2761
Red Cat Holdings
RCAT
$1.58B
| $88.9K | ﹤0.01% |
+34,982
| New | +$83.3K |
|
2762
Werewolf Therapeutics
HOWL
$18.6M
| $87.8K | ﹤0.01% |
41,413
+3,779
| +10% | +$8.6K |
|
|
ADVM
2763
DELISTED
Adverum Biotechnologies
ADVM
| $83.6K | ﹤0.01% |
+11,915
| New | +$86.5K |
|
|
BLDP
2764
Ballard Power Systems
BLDP
$790M
| $80.6K | ﹤0.01% |
44,869
+1,064
| +2% | +$2.13K |
|
2765
Expensify
EXFY
$202M
| $79.7K | ﹤0.01% |
+40,687
| New | +$84.5K |
|
|
GBIO
2766
DELISTED
Generation Bio
GBIO
| $77.4K | ﹤0.01% |
3,132
-47
| -1% | -$1.24K |
|
2767
Paysign
PAYS
$723M
| $75.4K | ﹤0.01% |
20,558
-820
| -4% | -$3.73K |
|
2768
Lifecore Biomedical
LFCR
$181M
| $71.4K | ﹤0.01% |
14,481
-17,501
| -55% | -$91.4K |
|
|
CLYM
2769
Climb Bio
CLYM
$827M
| $70.7K | ﹤0.01% |
+13,885
| New | +$98.2K |
|
2770
Amylyx Pharmaceuticals
AMLX
$2.6B
| $68.2K | ﹤0.01% |
21,049
+2,008
| +11% | +$4.51K |
|
|
VIGL
2771
DELISTED
Vigil Neuroscience
VIGL
| $67.9K | ﹤0.01% |
+19,970
| New | +$74K |
|
|
LAR
2772
Lithium Argentina AG
LAR
$1.12B
| $62.9K | ﹤0.01% |
19,212
+532
| +3% | +$1.48K |
|
|
AEVA
2773
Aeva Technologies
AEVA
$1.75B
| $62.7K | ﹤0.01% |
19,049
+3,785
| +25% | +$11.3K |
|
|
SEG.RT
2774
DELISTED
Seaport Entertainment Group Inc. Rights (expiring October 10, 2024)
SEG.RT
| $61.6K | ﹤0.01% |
+20,892
| New | +$60.1K |
|
|
QIPT
2775
DELISTED
Quipt Home Medical
QIPT
| $61.4K | ﹤0.01% |
+21,136
| New | +$65.2K |
|
Similar funds
American Century Companies's Q3 2024 Portfolio in Review
As of Q3 2024, American Century Companies held 3,003 positions worth $172B, up 5.3% from $163B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
American Century Companies's Q3 2024 filing shows 117 new, 1,782 increased, 832 reduced and 125 closed positions. Its largest new stake was Talen Energy Corp: 344,591 shares worth $61.4M. The largest sale was Visa, an estimated $486M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Financials and Consumer Discretionary.
- American Century Companies's largest Q3 2024 buy was Talen Energy Corp: 344,591 shares worth $61.4M.
- American Century Companies added most to Broadcom in Q3 2024, an estimated $233M increase.
- American Century Companies's biggest Q3 2024 reduction was Visa, cutting an estimated $486M.
- American Century Companies fully exited Encore Wire Corp in Q3 2024, selling an estimated $106M.
- American Century Companies's ten largest holdings make up 26% of its $172B portfolio in Q3 2024.
- American Century Companies opened 117 new positions and closed 125 in Q3 2024.
- American Century Companies's portfolio value rose 5.3% quarter-over-quarter to $172B.
Based on American Century Companies's 13F filing for Q3 2024, filed 12 Nov 2024.